ACUR - Acura Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
8.24M
Enterprise Value 3
14.14M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
29.55
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
50.67
Enterprise Value/EBITDA 6
-4.83

Trading Information

Stock Price History

Beta (3Y Monthly) 1.51
52-Week Change 3164.71%
S&P500 52-Week Change 318.11%
52 Week High 30.6300
52 Week Low 30.0600
50-Day Moving Average 30.3600
200-Day Moving Average 30.2693

Share Statistics

Avg Vol (3 month) 35.4k
Avg Vol (10 day) 34.38k
Shares Outstanding 521.3M
Float 8.24M
% Held by Insiders 152.76%
% Held by Institutions 19.33%
Shares Short (Jan 31, 2017) 489.85k
Short Ratio (Jan 31, 2017) 40.73
Short % of Float (Jan 31, 2017) 41.20%
Short % of Shares Outstanding (Jan 31, 2017) 40.76%
Shares Short (prior month Dec 30, 2016) 476k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Aug 28, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,148.03%

Management Effectiveness

Return on Assets (ttm)-80.28%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)279k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-66.20%
Gross Profit (ttm)-1.35M
EBITDA -2.93M
Net Income Avi to Common (ttm)-3.14M
Diluted EPS (ttm)-0.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)95k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.20

Cash Flow Statement

Operating Cash Flow (ttm)-3.34M
Levered Free Cash Flow (ttm)-2.2M